TNFα-induced expression of the IL-35 receptor IL12Rβ2 already on 4T1 mammary cancer cells in the primary tumor, rendered these cells more susceptible to the effects of IL-35 secreted from MAMs upon arrival at the lung metastatic site. The gene discussed is TNF; the disease is neoplasm.